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Orbital Metastasis with Enophthalmos: 
A Review of the Literature 
David M. Reifler, MD* 
Orbital metastasis is associated with enophthalmos in up to 
one third of all cases. After analyzing the clinical and 
pathologic features In 25 reported cases of enophthalmic 
orbital metastasis, the condition was found to almost 
exclusively affect females, usually in the 60 to 70 age group. 
The right orbit was the most commonly affected. The 
primary lesion was located in the breast in 7 9 (76%) cases 
and in the abdomen in 6 (24%) cases. In one third of the 
cases, the manifestations of the orbital metastasis were 
recognized before diagnosing the primary lesion. The most 
common presenting features were diplopia with ophthalmo-
plegia, ptosis, and decreased vision. Enophthalmos was 
usually less than 6 mm. 
The clinical findings of enophthalmos, ophthalmoplegia, 
blepharoptosis, and a resistance to ocular retropulsion 
strongly suggests the presence of an orbital metastasis, even 
in patients without a previous history of cancer. Following 
a thorough systemic evaluation, an open orbital biopsy 
should be performed, if possible, to confirm the pathologic 
diagnosis. Special histologic techniques and laboratory 
studies may be valuable in directing further palliative 
therapy. 
M etastasis of adenocarcinoma to the orbit is generally 
manifested by diplopia and blepharoptosis, followed by the 
development of pain, swelling, and exophthalmos (1), 
Henderson (2) has emphasized the clinical syndrome of the 
scirrhous types of metastatic carcinoma. While the initial 
orbit symptoms are similar to those of other adenocarcino-
mas, the diffusely infiltrating tumor may lead to a progres-
sively immobilized globe with enophthalmos rather than 
exophthalmos. 
Less than 2 % of all orbital tumors are associated with 
enophthalmos. Henderson (2) found 6 (1.2%) cases among 
the Mayo Clinic series of 465 orbital tumors, while Ossoinig 
(3) recorded 3 (1.8%) cases among 1 70 orbital tumors. The 
percentage of tumors with enophthalmos in these two series 
increased significantly to 19% and 33%, respectively, when 
the tabulations considered only the tumors that were 
metastatic to the orbit. This higher incidence is probably 
related to breast carcinoma being the most common primary 
site of orbital metastases, with about 20% to 25% of these 
orbital breast metastases developing enophthalmos (1,2). 
Although orbital metastasis with enophthalmos is decidedly 
more rare than metastasis with exophthalmos, the recogni-
tion of this unique syndrome is of great diagnostic impor-
tance. This paper reviews the literature concerning enoph-
thalmic orbital metastasis.t 
Number of Cases 
Twenty-four cases of enophthalmic orbital metastasis have 
been reported in the literature (2-14). In another case, the 
clinical presentation and special histochemical findings have 
been described (15). A summary of these 25 cases is listed 
in Table I. Among those reported. Cases 3,8,11,12, and 20 
were mentioned in passing as part of the discussions that 
emphasized other allied aspects of either primary or 
metastatic orbital tumors. Of the two cases mentioned by 
Ferry (8), one (Case 7) had been previously reported by 
Sachs and O'Crady (7). This same case was subsequently 
included by Font and Ferry (1) in their classic article. 
Although based on a few reported cases, a relatively 
widespread appreciation exists concerning the unusual 
behavior of metastatic scirrhous carcinoma in the orbit. As 
this syndrome has become somewhat more understood, 
many cases undoubtedly have gone unreported. Ossoinig 
(3) has reported three cases of enophthalmic orbital metasta-
sis and has since seen an additional three cases, two ofwhich 
arose from primaries in the breast and one that originated 
in the abdomen (Ossoinig, personal communication, july 9, 
1985). These latter three cases and others whose documen-
tation could not be reviewed were not included in this study. 
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Lateralization 
The majority of enophthalmic orbital metastases have 
shown involvement of the right orbit. Of 21 unilateral cases 
in which the location of metastasis was specified, 16 (76%) 
involved the right orbit, and 5 (24%) involved the left orbit. 
These findings are in contrast to orbital metastasis in general, 
as various authors have noted involvement of both sides 
with about equal frequency (1,16) or even a left-sided 
predominance (1 7-19). The apparent right-sided preponder-
ance of enophthalmic orbital metastases is therefore strik-
ingly paradoxical. The left orbit was formerly believed to 
experience more metastases, since the left common carotid 
artery arises directly from the aorta (17-20). 
Bilateral involvement occurs in about 25% of the cases with 
metastatic neoplasms to the eye and adnexa (21). However, 
only 1 (4%) of the 25 cases reviewed showed bilateral 
enophthalmic orbital metastases (1). (Except for the bilateral 
involvement, the clinical features in this case were similar 
in other respects to unilateral cases as will be described.) 
In the series considering all forms of orbital metastasis, the 
incidence of bilateral metastases was found to be approxi-
mately 7% to 9% (1,2) at the initial presentation, Henderson 
(2) observed that this rate virtually doubled as extended 
follow-up of patients with unilateral metastases disclosed 
subsequent contralateral involvement. 
Because the initial symptoms are rather undramatic in 
scirrhous orbital metastases, whether there may be an occult 
involvement of the contralateral orbit is questionable. 
Sensitive noninvasive studies such as computed tomo-
graphic (CT) scanning and ultrasonography have failed to 
demonstrate contralateral involvement in such cases. This 
provides further evidence for the rarity of bilateral orbital 
metastases with enophthalmos. 
Site of the Primary Tumor 
The orbital metastasis arose from carcinoma of the breast 
in 19 (76%) of the 25 cases reviewed. Breast carcinoma 
involved the right side in two cases, the left side in four cases, 
and apparently both sides in two cases. The side of the breast 
involvement was not stated in 11 cases. In the remaining 
6 (24%) cases, the carcinoma originated in the abdomen 
(Table I), Some authors have emphasized only linitis plastica 
of the stomach as an abdominal source of orbital metastasis 
with enophthalmos (12), In this series, however, three cases 
involved carcinomas arising from the stomach while other 
primary sites were documented (3,14), including one from 
the colon (Case 5), one from the pancreas (Case 24), and 
one that was not further specified (Case 6), 
Number 
ol 
Patients 
7 5 - 7 8 
Fig 1 
Age distr ibut ion of 19 cases w i th enophthalmic orbital metastasis. 
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Table I 
Summary of Reported Cases of Orbi ta l Metastasis Associated w i th Enophthalmos 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 1 
12 
13 
14 
15 
16 
17 
18 
20 
2 1 
22 
23 
JJ 
2' 
Author/Year 
Lawson, 1910 
Biro, 1941 
Hoyt, 1966 
Ossoinig, 1969 
Ossoinig, 1969 
Ossoinig, 1969 
Sachs, 1971 
Ferry, 1973 
Henderson, 1973 
Henderson, 1973 
Henderson, 1973 
Henderson, 1973 
Henderson, 1973 
Henderson, 1973 
Manor, 1974 
Radnol, 1975 
Barroche, 1979 
Larmande, 1979 
19 Larmande, 1979 
Hesselink 
Cline, 1984 
Cline, 1984 
Cline, 1984 
Cline, 1984 
Reifler, 1985 
Age/Sex 
*/F 
41/E 
* /F 
78/E 
62/F 
56/F 
47/F 
*/F 
68/F 
45/E 
*/F 
•/E 
60/F 
63/F 
72/E 
50/F 
55/E 
51/E 
68/F 
65/E 
53/E 
58/F 
77 /M 
62/F 
Orbit with Location of 
Metastasis Primary 
Amount of 
Enopthal-
mos (mm) 
R,L 
R 
K 
R 
i-; 
R 
L 
R 
R 
L 
L 
I. 
Breast (R) 
Breast (R,L) 
Breast I 
Breast t 
Colon 
Abdomen 
Breast (R) 
Breast I 
Breast' 
Breast' 
Breast' 
Breast' 
Stomach 
Stomach 
Breast (L) 
Breast (R,L) 
Breast (L) 
Stomach 
Breast (L) 
Breast' 
Breast' 
Breast' 
Breast' 
Abdomen 
Breast (L) 
* unknown 
5 
11 
4 
4 
* 
2 
5 
3 
I 
4 
10 
4 
2 
4 
3 
2 
5 
2 
' side not indicaied 
Age and Sex 
The age of the patient was included in 19 of the 25 cases 
reviewed. The average age was 59.5 years with a range of 
41 to 78 years (Table I). Over two-thirds of these cases 
occurred in the 60 to 70 age group with a peak occurrence 
in the early seventies (Fig 1). 
Because of the preponderance of breast carcinoma as the 
source of enophthalmic metastasis, this condition was found 
to affect females almost exclusively (Table I), Although 
breast carcinoma is known to occur in males, and though 
an instance of ocular metastasis from breast carcinoma in 
a male has been reported (22), any documentation of men 
who suffered an orbital metastasis from a primary in the 
breast is unknown. Only one instance (Case 24) of enoph-
Ptosis 
Present 
Present 
Present 
Present 
Present 
Present 
Preseni 
Present 
Present 
Absent 
Present 
Present 
Present 
Ophthalmo-
plegia 
Present 
Present 
Present 
Present 
Present 
Present 
Preseni 
Present 
Present 
Present 
Present 
Present 
Present 
Present 
Present 
Present 
Preseni 
Interval from Diagnosis 
of Primary to Diagnosis 
of Metastasis 
-E 6 y 
+ 1 y 
Unspecified 
+ 2 y 
Metastasis first 
+ 1 8 mo 
-E 6 y 
Unspecified 
Metastasis first 
-E 4 y 
Unspecified 
Unspecified 
Unspecified 
Metastasis first 
-E 6 mo 
+ 5 y 
Metastasis first 
Metastasis first 
+ 1 y 
Unspecified 
+ 51 mo 
-E about 5 y 
-E aboul 5 y 
Unspecified 
Metastasis first 
Decreased 
Vision 
Present 
Present 
Present 
Absent 
Present 
Absent 
Absent 
Present 
Pain 
Absent 
Absent 
Absent 
Absent 
Absent 
Present 
Present Present 
Absent Present 
Present Present 
thalmic orbital metastasis has been reported in a male (14), 
and though the source of the primary was not known, a 
carcinoma involving the pancreas was strongly suspected. 
Temporal Relationship: Diagnosis of Primary 
Versus Metastatic Lesions 
Information regarding the temporal relationship between the 
time of the respective manifestations and/or diagnoses of 
the primary and metastatic lesions was available in 18 of the 
25 cases reviewed (Table II), In 12 (66,7%) of these 18 
cases, the manifestations of orbital metastasis occurred 
between six months and six years following the diagnosis 
of the primary carcinoma, with an average interval of about 
3,5 years. In the remaining 6 (33.3%) cases, the manifesta-
tions of the orbital metastasis were recognized before 
diagnosing the primary lesion. 
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Table II 
Temporal Relationship Between Presentation of Primary and Meta-
static Lesions in Orbi tal Metastases Associated w i th Enophthalmos: 
Analysis by Site of Primary Lesion 
Number (% of Cases) 
Presentation of Lesions 
Antecedent or simultaneous 
presentation of metastasis 
Subsequent presentation of 
orbital metastasis 
Unspecified interval 
Total number of cases 
Primary in 
Breast 
3 (15.8%) 
11 (57.9%) 
Primary in 
Abdomen 
5 (50.0%) 
1 (16.7%) 
5 (26.3%) 2 (33.3%) 
Total 
6 (24%) 
12 (48%) 
7 (28%) 
19(100.0%) 6(100.0%) 25 (100%) 
The phenomenon of orbital metastasis as the presenting 
manifestation of a carcinoma has been emphasized in the 
literature reviewed (2,3,11,12). Orbital metastasis may also 
comprise the first evidence of disseminated malignancy in 
patients with a previous history of carcinomas. Because the 
initial ophthalmic manifestations of orbital metastasis with 
enophthalmos may be subtle and a history of carcinoma 
remote or even absent, the proper diagnosis represents a 
diagnostic challenge. Nevertheless, the ophthalmologist is 
certainly in a unique position to properly commence an 
evaluation of such patients, who may greatly benefit from 
subsequent palliative therapy. 
Among the cases reviewed, the tendency for an antecedent 
or simultaneous presentation of orbital metastasis was much 
more evident in carcinomas arising in the abdomen than 
those arising in the breast. The three instances (Cases 9,17, 
and 25) of orbital metastasis occurring from breast carci-
noma before the diagnosis of the primary tumor was 
unusual. In contrast, only once instance (Case 6) presented 
a well-documented abdominal carcinoma in which the 
primary tumor was diagnosed before manifestations of the 
orbital metastasis (3), Even in this case, the patient was 
apparently not aware that diffuse scirrhous abdominal 
carcinoma had been diagnosed at the time of a cholecystec-
tomy, 18 months before ophthalmic presentation (Ossoinig, 
personal communication, July 9, 1985), 
Signs and Symptoms 
The amount of enophthalmos was recorded in 19 of the 
cases reviewed. In all but two cases, the enophthalmos 
measured less than 6 mm but ranged from 1 mm to as much 
as 11 mm (Table I). The enophthalmos was most commonly 
in the range of 3 mm to 4 mm (Fig 2). The two instances 
(Cases 5 and 18) of profound metastatic enophthalmos (11 
mm and 10 mm) both arose from abdominal primaries 
(colon and stomach, respectively). 
Number 
of 
Patients 
5 -
4 -
3 -
2 -
1 -
1 2 3 4 5 6 7 8 9 10 
Amount of Enophthalmos (mm) 
11 
Fig 2 
Amount of enophthalmos in 19 cases of enophthalmos-producing orbital metastasis. 
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Fig 3 
A 61-year-old woman w i th enophthalmos and ophthalmoplegia caused by inf i l t rat ing lobular breast carcinoma metastatic to orbi t : (A) at tempted upward gaze, (B) right 
gaze, (C) primary posit ion, (D) left gaze, and (E) downward gaze. Note also blepharoptosis and lack of l id movement. 
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The most common presenting features of enophthalmic 
orbital metastasis were diplopia and a limitation of ocular 
motility (Fig 3). These features were present in virtually all 
of the sufficiently detailed reports. The first symptom usually 
to be noticed by the patient was diplopia, a feature that is 
common with orbital metastases in general but one that 
often appears much later in cases of primary orbital tumors 
(20). However, in contrast to orbital metastases in general, 
most of the enophthalmic metastases seemed to havea more 
insidious onset and gradually progressive course. The 
diplopia is surprisingly well tolerated in many cases of 
enophthalmic metastasis (Ossoinig, personal communica-
tion, July 9, 1985). When the eyes remain aligned in the 
primary position (eg. Case 7), patients may be unaware of 
diplopia until it is brought to their attention (7). The 
mechanics of the restricted ocular motility are well docu-
mented by Lancaster projection testing (11,12), 
Sachs and O'Crady (7) emphasized the similarities of 
physical findings between patients with essential facial 
hemiatrophy (Parry-Romberg syndrome) and enophthalmic 
orbital metastasis. The former condition is also associated 
with enophthalmos and restricted ocular motility. For this 
reason, an erroneous diagnosis of Parry-Romberg syndrome 
is rarely made in cases of orbital metastasis. However, 
essential facial hemiatrophy is characterized by a more 
regional atrophy of facial tissue including skin, subcutaneous 
fat, and connective tissue, bone, and muscle. The diagnosis 
of "early" essential facial hemiatrophy should be viewed 
with suspicion when based solely on orbital findings. 
In the cases described herein, ptosis was frequently seen and 
usually in greater amount than could be accounted for by 
the enophthalmos alone (Fig 3). The movements of the lid 
and the blinking mechanisms tend to be severely impaired, 
probably because of scirrhous infiltration surrounding the 
levator. Relative corneal hypesthesia may occur and, com-
bined with a mechanical dysfunction of the lid movement, 
leads to further corneal decompensation. Despite extensive 
infiltration that virtually encases the deeper orbital struc-
tures, the skin remains remarkably supple and normal in 
appearance without ulceration. 
A profound resistance to attempted retropulsion of the 
globe, when seen in conjunction with enophthalmos, is an 
important diagnostic sign. Replacing compliant fat with a 
dense fibrous stroma results in an orbit that feels "rock 
hard." However, because ofthe diffuse scirrhous infiltration, 
a discrete mass sometimes cannot be palpated. The findings 
of enophthalmos, ophthalmoplegia, and resistance to ret-
ropulsion of the globe should strongly suggest a scirrhous 
carcinoma metastatic to the orbit even when there is no 
previous history of a primary tumor. 
Localized pain has been emphasized as a prominent feature 
of orbital metastasis (1,2). However, in many cases of 
enophthalmic orbital metastasis, pain was either absent or 
minimal (3). This may be due in part to the absence of a 
sudden, dramatic onset of pain and a lack of acute 
inflammatory edema. Conjunctival hyperemia and chemosis 
is frequently noted, but this may be related to exposure as 
well as elevated venous pressure. 
Decreased vision was noted frequently among the cases 
reviewed. A number of factors probably contributed to 
visual decline including keratopathy, hypermetropia (3), 
glaucoma (9), choroidal metastasis (14), and papilledema 
(6). Concurrent orbital and ocular involvement has been 
observed in occasional cases of metastatic carcinoma 
(8,19,23). One (4%) of the cases of orbital metastasis with 
enophthalmos (Case 21) had an associated intraocular 
metastasis on the same side (14). 
Diagnostic Studies 
Radiology 
Plain radiographs are typically normal in cases of orbital 
metastasis associated with enophthalmos. Cases of scirrhous 
orbital carcinoma are typically not associated with destruc-
tion of the orbital bones. Apparently, the one case (Case 15) 
that showed an extensive destruction of bone was not a 
scirrhous carcinoma. The enophthalmos in this case was 
probably due to the bone destruction itself. While minimal 
bone destruction was noted in other caoes (13), it probably 
was insufficient to account for the enophthalmos. 
In general, about 68% of orbital metastases are associated 
with aggressive bone destruction, with a large number of 
these tumors showing direct intracranial extension (23). 
With the exception of the few cases noted previously, the 
orbital metastases in this series seemed to behave differently 
in this respect. 
Computed tomography 
Reproductions and descriptions of orbital CT scans were 
included in some of the more recent reports of orbital 
metastasis with enophthalmos (Cases 17,20,21, and 25). 
The amount of enophthalmos can easily be estimated from 
axial projections, although both axial and coronal views are 
recommended to accurately assess the character, extent, 
and anatomic relationships of the metastatic tumor. Evi-
dence of local infiltration involving both the intraconal and 
extraconal compartments as well as extraocular muscle 
could be discerned. In one case (Case 25), enhancement of 
the lesion and the optic nerve following intravenous contrast 
injection was misinterpreted by the radiologist as represent-
ing optic glioma or meningioma (Reifler, unpublished data, 
January 17,1985). Actually, the optic disc enhancement was 
probably due to papilledema. 
Other radiographic studies 
Carotid arteriography and orbital venography may be 
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normal in cases of orbital metastasis with enophthalmos 
(11). Because of the sensitivity of CT scanning and orbital 
ultrasonography, these studies are probably unnecessary 
except in unusual circumstances. 
Ultrasonography 
The A-scan and B-scan ultrasonographic findings of enoph-
thalmic orbital metastasis have also been reported (3). The 
lack of an acoustic interface between the tumor and adjacent 
orbital tissue correlates well with the histological absence 
of encapsulation, although the pattern of the adjacent orbital 
fat may be irregular. In the densest areas of infiltration, there 
is a remarkable lack of internal reflectivity, resulting in an 
acoustically "empty" or "lucent" zone on the B-scan, 
Apparently, the relatively dense desmoplastic reaction 
results in a lack of acoustic interfaces. 
Fluorescein angiography 
In cases of orbital metastasis, ancillary studies of the ocular 
fundus can be helpful sometimes in characterizing associ-
ated pathology of the choroid, retina, and optic disc. In 
particular, choroidal metastasis (24), striae, and papilledema 
(6) can be documented by fundus photography and fluores-
cein angiography. 
Electromyography 
No particular electromyographic abnormalities were noted 
in one case of orbital metastasis with enophthalmos where 
this study was performed (11). 
Carcinoembryonic antigen 
In the past, the serial measurement of serum carcinoembry-
onic antigen (CEA) in cases of orbital metastasis has been 
emphasized (25,26). However, serum CEA levels have no 
specificity and little diagnostic value in the evaluation of 
orbital metastases. Serum CEA levels were within a normal 
range in the one case of enophthalmic orbital metastasis 
where this study was performed (Case 25). 
Biopsy 
Even in patients with presumed orbital metastasis and a 
previous history of carcinoma, an attempt should be made 
to obtain an orbital specimen for cytologic or histo-
pathologic diagnosis. This is to assure the implementation 
of an appropriate treatment regimen by consulting medical 
oncologists and radiation therapists. The histopathology of 
enophthalmos-producing metastases usually reveals infiltra-
tion with a dense fibrous stroma, and it may be difficult to 
distinguish between an abdominal and mammary source. In 
one of the cases (Case 18) reported by Larmande and 
Rossazza (12), an orbital metastasis arising from a primary 
in the stomach occurred in a patient with a previous history 
of breast carcinoma. An orbital biopsy confirmed the 
presence of scirrhous carcinoma that was presumed to be 
a metastasis from the breast. The gastric carcinoma went 
undiagnosed for another year until abdominal complications 
ultimately led to the patient's death. 
An orbital biopsy may be easy to perform, particularly if 
there is a palpable, anteriorly situated component of the 
lesion. Metastatic tumors that are located posteriorly are 
technically a more difficult biopsy, especially if the tumors 
are located medially. Because the orbit is typically noncom-
pliant in cases of scirrhous metastasis, access to the medial 
orbital region may require removal of the lateral wall for 
adequate exposure. 
A negative fine-needle aspiration biopsy is a characteristic 
of tumors with a predominantly fibrous matrix where 
intercellular cohesion is strong and cellularity is diminished 
(27). Fine-needle aspiration biopsy may therefore be nondi-
agnostic in cases of orbital metastasis with enophthalmos 
(15). For debilitated patients or those refusing major surgery, 
a large bore-needle biopsy (16- to 18-gauge) may be 
considered to obtain a cylinder of tissue that is readily 
processed by paraffin embedding rather than cytologic 
techniques (28). 
Assays for hormone receptors 
Bullock and Yanes (25) have described the usefulness of 
steroid-hormone receptor assays in patients with breast 
carcinoma metastatic to the orbit. In women with metastatic 
breast carcinoma, the rate of objective response to endo-
crine therapy is much improved when the cancerous tissues 
contain estrogen receptors (29). In one case of orbital 
metastasis with enophthalmos (Case 25), steroid-hormone 
receptors were documented using this technique as well as 
with fluorescent histochemical techniques. 
Because of the low yield of needle aspiration biopsy in cases 
of scirrhous tumors and the potential value of special 
techniques requiring an adequate tissue specimen, an open 
orbital biopsy seems the best way to harvest tissue in 
suspected cases of orbital metastasis with enophthalmos. 
Pathologic Findings 
Histopathology 
The histologic features of orbital metastasis are generally 
typical of scirrhous carcinoma. The degree of cellular 
differentiation varies between cases. The orbital fat shows 
infiltration of small carcinoma cells occurring in small nests 
or a single file distribution. A proliferation of fibrous tissue 
occurs adjacent to the sheets and nests of the infiltrating 
cancer cells. The interrelationships between the neoplastic 
infiltration, the decrease in the volume of orbital fat, and the 
fibrous proliferation remain to be elucidated. The clinico-
pathologic correlations between these destructive processes 
and findings such as enophthalmos and ophthalmoplegia 
also remain to be defined. 
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In cases of orbital metastasis, special histologic stains such 
as mucicarmine, alcian blue, and periodic acid-Schiff can 
further characterize the biochemical composition of cyto-
plasmic organelles and thus may be used to accurately 
predict the site of the primary neoplasm (1). The diagnosis 
of a mucus-secreting adenocarcinoma can easily be con-
firmed by these staining techniques. Documentation of 
steroid-hormone receptors in orbital metastases may be 
accomplished with quantitative assays, fluorescence micros-
copy, or immunoenzyme techniques (30). The increasing 
availability of clinically useful tissue-specific antibody-conju-
gated reagents has proven valuable in the study of some 
orbital metastases (31), However, immunoperoxidase tech-
niques have not yet been applied to the study of enophthal-
mic orbital metastasis. 
Electron microscopy 
The electron microscopic findings were presented in only 
one of the cases reviewed (Case 16). Groups of tumor cells 
were found embedded among collagen fibers, correlating 
with the light microscopic findings of abundant scirrhous 
connective tissue. The tumor cells were spindle-shaped and 
poorly differentiated, but with scanning electron microscopy 
they often assumed a club-like appearance and had clus-
tered in small groups. 
Treatment 
Palliative treatment should be sought for patients with 
biopsy-proven orbital metastasis. In addition to the manage-
ment of ocular problems such as corneal exposure, various 
modes of treatment include localized radiation therapy, 
systemic chemotherapy, and endocrinologic therapy in 
some cases. Radiation therapy may cause a temporary 
increase in periorbital inflammation that quickly subsides 
after treatment has ended. Antiestrogenic agents such as 
tamoxifen citrate are particularly efficacious when estrogen 
receptors have been detected in primary and metastatic 
tumor specimens. Systemic therapy can also have a benefi-
cial effect on other sites of metastasis. Palliative treatment 
was successful in several of the cases in improving the lid 
function and reducing the amount of enophthalmos. 
Prognosis 
In the cases reviewed, the data were not sufficient to 
generate meaningful mortality statistics. In many of the 
cases, follow-up data either was not given or covered only 
short periods of time. However, with palliative therapy, 
several patients did well for over one year while others 
experienced the complications of diffuse metastatic carci-
noma within a few months. In cases of metastatic carcinoma 
to the orbit in general, the median survival has been reported 
to be about 1 6 months from the time of surgery (8). Whether 
the survival rate in cases of enophthalmic orbital metastasis 
would be any different is unknown. 
Etiology of Ophthalmoplegia and 
Enophthalmos 
Many theories have been proposed to explain the etiology 
of ophthalmoplegia and enophthalmos in cases of orbital 
metastasis. It has been well recognized that ophthalmoplegia 
can be produced by discrete orbital carcinomatous metasta-
sis in the extraocular muscles and motor nerves (32), Ptosis 
and ophthalmoplegia associated with extraocular muscle 
infiltration may also be seen in cases of primary orbital 
lymphoproliferalive disorders (33). Various diseases associ-
ated with infiltration involving extraocular muscles have 
been observed to produce an acquired orbital retraction 
syndrome (34), However, the retraction of the globe is 
present only with attempted versions within the field of 
action opposite the involved muscle. Acquired orbital 
retraction syndrome due to infiltrative orbital disease also 
has been described in cases associated only with exophthal-
mos. Since ophthalmoplegia occurs so early in the course 
of scirrhous orbital metastasis, perhaps subtle retraction with 
attempted eye movements might be observed early in such 
patients. However, by the time enophthalmos develops, 
replacement of the orbital tissues is usually quite extensive, 
and noncompliance within the orbit probably would prevent 
such retractions from occurring. 
Orbital neoplastic infiltration alone does not explain the 
phenomenon of enophthalmos. In general, three mecha-
nisms alone or in combination can lead to enophthalmos: 
structural abnormality, fat atrophy, and traction. Various 
conditions that may be associated with enophthalmos have 
been reviewed by Cline and Rootman (14) and are summa-
rized in Table III, Sachs and O'Crady (7) postulated that 
normal orbital fat is replaced by a tumor that has a relatively 
Table III 
Condit ions Associated w i th Enophthalmos (after Cline and 
Rootman [14]) 
Structural abnormalities 
Orbital asymmetry 
Maxillary hypoplasia 
Microphthalmos 
Destruction of the orbital bones (sinusitis, neoplasia) 
Trauma 
Absence of sphenoid wing as in neurofibromatosis 
Orbital fat atrophy 
Orbital varix 
Scleroderma 
Following irradiation 
Following orbital hemorrhage 
Lipodystrophy 
Repeated self-inflicted pressure 
Traction 
Nystagmus retractorus 
Following surgical shortening of an extraocular muscle 
Following injection of succinylcholine (transient) 
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smaller volume and that maturation of the collagen matrix 
is associated with contracture in a manner similar to that 
seen in maturing scar tissue. Henderson (2) emphasized this 
proposed mechanism of contraction causing the muscles, 
nerves, and surrounding soft tissues to become "so entwined 
and infiltrated by the scirrhous tumor that the helpless eye 
soon is immobilized and pulled posteriorly." 
As previously mentioned, one report (Case 15) was given 
by Manor (9) in which the enophthalmos was produced by 
extensive bone destruction. This case did not seem to follow 
the clinical picture of scirrhous carcinoma and therefore was 
probably unique among the cases reviewed. As Cline and 
Rootman (14) noted, the various causes of enophthalmos 
may occur alone or in combination with one another. 
Further studies may substantiate the proposed mechanisms 
producing ophthalmoplegia and enophthalmos in cases of 
orbital metastasis. As Barroche et al (11) said: "Whilst the 
pathogenesis of the ophthalmoplegia is evident, that of the 
enophthalmos is purely conjectural." 
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